Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S2W-19087 · Session 2

When NHS Quality Improvement Scotland will make its announcement on donepezil, rivastigmine, galantamine and memantine for the treatment of…

Answered Asked by Nanette Milne Con Lodged 7 Sep 2005

The question

To ask the Scottish Executive when NHS Quality Improvement Scotland will make its announcement on donepezil, rivastigmine, galantamine and memantine for the treatment of Alzheimer's disease.

The answer

Answered by Andy Kerr on 14 Sep 2005 · 7 days after it was lodged, on time

NHS Quality Improvement Scotland will consider any final recommendation from the National Institute for Health and Clinical Excellence (NICE) on this matter and consider how it might apply to NHS Scotland. NICE is currently gathering further information on these drugs from the respective manufacturers.

In the Official Report

No contribution in the Official Report cites S2W-19087 by reference.